After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
It's too cheap for a biotech giant with years of patent protection for key products and great cash flow.
Merck (MRK) announced that its experimental Ebola vaccine V920 has been put under 'accelerated' review in the U.S. and the EU.
A slew of corporate earnings and closely watched Federal Reserve meeting are in focus for the week of July 25.
Optimism is warranted over the long haul, but investors probably face a short-term headache. Here are the crucial numbers and events to watch in the week ahead.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.